Skip to main content

Table 1 Baseline demographics, mesothelins and survival

From: A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma

  Post-chemotherapy Non-chemotherapy
Number 23 18
Median age (range) 69 (58–77) 75 (67–83)
Male/Female 22/1 13/5
Histology
 Epithelioid 14 11
 Biphasic 3 1
 Sarcomatoid 5 4
 Unknown 1 2
Baseline mesothelin
 Median 1.9 3.4
  (IQR) (1.2–13.4) (1.2–6.4)
Survival (months)
 Median 17 10
  (IQR) (14–26) (7–22)